Artal Group S.A. Igm Biosciences, Inc. Transaction History

Artal Group S.A.

$1.58 Billion
Q2 2024

A detailed history of Artal Group S.A. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 3,330,422 shares of IGMS stock, worth $59.4 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

3,330,422

Previous 3,080,422 8.12%

Holding current value

$59.4 Million

Previous $29.7 Million 23.03%

% of portfolio

1.45%

Previous 1.6%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $1.63 Million - $2.87 Million	250,000 Added 8.12%	3,330,422 $22.9 Million
Q1 2024 May 13, 2024	SELL	$8.68 - $17.36 $173,600 - $347,200	-20,000 Reduced 0.65%	3,080,422 $29.7 Million
Q4 2023 Feb 09, 2024	BUY	$3.94 - $8.79 $2.28 Million - $5.08 Million	578,178 Added 22.92%	3,100,422 $25.8 Million
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $108,729 - $171,808	12,272 Added 0.49%	2,522,244 $23.3 Million
Q1 2023 May 12, 2023	BUY	$13.74 - $25.76 $824,015 - $1.54 Million	59,972 Added 2.45%	2,509,972 $34.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $6.94 Million - $12.2 Million	450,000 Added 22.5%	2,450,000 $55.7 Million
Q1 2022 May 12, 2022	BUY	$13.42 - $29.73 $6.71 Million - $14.9 Million	500,000 Added 33.33%	2,000,000 $53.5 Million
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $4.14 Million - $9.96 Million	150,000 Added 11.11%	1,500,000 $44 Million
Q3 2021 Nov 12, 2021	BUY	$65.76 - $90.65 $16.4 Million - $22.7 Million	250,000 Added 22.73%	1,350,000 $88.8 Million
Q2 2021 Aug 13, 2021	SELL	$57.98 - $96.6 $1.45 Million - $2.42 Million	-25,000 Reduced 2.22%	1,100,000 $91.5 Million
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $5.37 Million - $9.09 Million	-75,000 Reduced 6.25%	1,125,000 $86.3 Million
Q4 2020 Feb 11, 2021	BUY	$47.41 - $115.03 $24.2 Million - $58.8 Million	511,090 Added 74.19%	1,200,000 $106 Million
Q3 2020 Nov 13, 2020	BUY	$43.0 - $84.01 $29.6 Million - $57.9 Million	688,910 New	688,910 $50.8 Million
Q1 2020 May 14, 2020	SELL	$31.51 - $73.75 $4.73 Million - $11.1 Million	-150,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.25 - $49.51 $862,500 - $2.48 Million	-50,000 Reduced 25.0%	150,000 $5.72 Million
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $3.55 Million - $4.86 Million	200,000 New	200,000 $3.55 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $517M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account